Background Epilepsy is associated with high rates of premature mortality, but the contribution of psychiatric comorbidity is uncertain. We assessed the prevalence and risks of premature mortality from external causes such as suicide, accidents, and assaults in people with epilepsy with and without psychiatric comorbidity.
Introduction
Epilepsy accounts for an estimated 0·7% of the global burden of disease. 1 It aff ects around 70 million people, 2 and contributes to over 17 million disability-adjusted life-years annually. 1 Premature mortality is substantial 3 and almost half of epilepsy-related deaths occur in those younger than 55 years, corresponding to standardised mortality ratios above 10 for hospitalised patients. 4 Suicide is associated with up to 5% of all epilepsy deaths, 5 but whether epilepsy is independently associated with suicide is unclear. One study suggested that epilepsy is an independent risk factor for suicide after controlling for psychiatric comorbidity, 6 but studies from Canada 7 and the UK 8 reported no independent relation. There have also been confl icting conclusions about whether epilepsy is a risk factor for suicide when psychiatric comorbidity is not present. 6, 7 Clarifi cation would assist national suicide prevention strategies that increasingly focus on high-risk populations, 9, 10 particularly if such groups can be identifi ed, and could also inform treatment guidelines.
Other major causes of epilepsy-related deaths are vehicle and non-vehicle accidents, 10, 11 which contribute to up to 16% of deaths. 12 Restrictions for drivers with epilepsy have probably contributed to death rates from motor vehicle accidents not being signifi cantly higher than that of the general population in certain countries. 7 However, the role of public health and education measures in reducing mortality from non-vehicle accidents in patients with epilepsy is uncertain. In particular, possible associations of non-vehicle accidental deaths with psychiatric disorders need clarifi cation, and previous studies have not investigated psychiatric comorbidity.
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In our 41-year population study of 69 995 individuals with epilepsy, we aimed to investigate prevalence and risks of premature mortality, and to address two specifi c issues. First, whether epilepsy is independently associated with external causes of death. To clarify this, we compared people with epilepsy with the general population and unaff ected sibling controls. If there is a link between epilepsy and death from external causes, the use of sibling controls enables clarifi cation of whether this association is consistent with a causal hypothesis or due to residual confounding, including genetic and early environmental factors. Second, we investigated the association of epilepsy with premature mortality in patients with and without comorbid psychiatric disorders.
Methods

Study setting
We linked several longitudinal, nationwide population registers in Sweden: the Patient Register (held at the National Board of Health and Welfare), the Censuses from 1970 and 1990 (Statistics Sweden), the MultiGeneration Register (Statistics Sweden), and the Cause-of-Death Register (National Board of Health and Welfare). The Multi-Generation Register connects every person born in Sweden from 1933 onwards and ever registered as living in Sweden after 1960 to their parents. 13 For immigrants, similar information exists for those who became citizens of Sweden before aged 18 years, together with one or both parents. In Sweden, all residents including immigrants have a unique ten-digit personal identifi cation number that is used in all national registers, thus making the linking of data possible. We selected a cohort of people born between 1954 and 2009, and followed them up for up to 41 years, from 1969 to the end of follow-up in 2009 (n=7 238 800). The Patient Registers started in 1969; hence we began our follow-up at that point, which meant that children diagnosed with epilepsy who died between 1954 and 1968 were not included in the cohort. A sensitivity analysis addressed whether this aff ected the main fi ndings. Using the Multi-Generation Register, we also identifi ed patients with epilepsy who had full siblings without epilepsy.
The Regional Ethics Committee at Karolinska Institutet approved the study (2009/939-31/5). Data were merged and anonymised by an independent government agency (Statistics Sweden), and the code linking the personal identifi cation numbers to the new case numbers was destroyed immediately after merging. Therefore, informed consent was not required.
Measures Epilepsy
Epilepsy was identifi ed through the National Patient Register, which includes individuals hospitalised (starting in 1969 but with total national coverage from 1987) or having outpatient appointments with specialist physicians (since 2001) in Sweden. 14 Patients with epilepsy had to have had at least one episode in which the diagnosis was made according to the International Classifi cation of Diseases (ICD) ICD-8 (1969 ICD-8 ( -1986 ; diagnostic codes 345.00-345.99), ICD-9 (1987 ICD-9 ( -1996 ; codes 345J, K, L, M, N, P, Q, W, X), or ICD-10 (from 1997 onwards; codes G40.1-G40.9, G41).
Diagnostic validity
Swedish patient register data for diagnoses have good to excellent validity for a range of disorders, including neurological conditions such as acute stroke 15 and Guillain-Barré syndrome, 16 and psychiatric illnesses such as bipolar disorder 17 and schizophrenia. 18 Overall, the positive predictive value of the inpatient register, in a recent review, was found to be 85-95% for most diagnoses. 19 Less is known about comorbidity, although one study found fair to moderate agreement for comorbid substance misuse in schizophrenia (κ=0·37, standard error 0·23, p<0·001, corresponding to 68% full agree ment). 20 Since only around 1% of hospital admissions have missing personal identifi cation numbers, 21 the register has been used in various epidemiological investigations.
22,23
Outcome measures
Data for causes of death were retrieved for all individuals who died between 1969 and 2009. The Cause of Death register, based on death certifi cates, covers over 99% of all deaths. 24 We extracted both all-cause mortality data and separately by ICD chapter, including external causes. Within external causes, we further examined deaths by suicide, vehicle and non-vehicle accidents, and assault. In line with previous work, 25 undetermined deaths (ICD codes Y10-Y34) were included as suicides since their exclusion would underestimate actual rates.
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Sociodemographic and psychiatric covariates
Mean lifetime disposable income (divided into thirds) was used as a proxy for income, and used as a dichotomous variable (lowest tertile vs top two tertiles). If this information was unavailable, family lifetime disposable income, or parents' lifetime disposable income was used instead and similarly divided into tertiles. Single marital status was defi ned as being unmarried at end of 
Analyses
For each patient, up to ten general population controls without any diagnosis of epilepsy were matched individually by birth year and sex (n=660 869). We estimated the association between having been diagnosed with epilepsy and causes of death, as per related work using matched or sibling controls, 20, 23 using the clogit command in Stata, version 12 (StataCorp). The clogit command fi ts conditional (fi xed eff ects) logistic regression models to matched case-control or cohort groups. We included three confounders (low income, single, and immigrant status) on theoretical grounds, based on related work in severe mental illness, 20, 27 and also tested whether they were each independently asso ciated with either case (epilepsy diagnosis) or con trol and outcome measures, respectively, in univariate analyses at the 5% level of signifi cance.
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Sibling control studies
To account for possible familial confounding, we did additional analyses that used unaff ected full siblings of patients as controls. In this analysis, we identifi ed as cases those individuals with epilepsy who also had full siblings without epilepsy, and these individuals were compared with their unaff ected full siblings (n=81 396) using matched conditional logistic regression, and analyses were adjusted for age and sex.
Sensitivity analyses
We also did the following subanalyses. First, we investigated categories of epilepsy and classifi ed them into four types according to the diagnosis at fi rst admission: complex partial seizures (ICD 33 , 345.9; ICD-9: 345L, 345P, 345Q, 345W, 345X; ICD-10: G40.4, G40.5, G40.6, G40.7, G40.8, G40.9, G41). 23 Second, based on International League Against Epilepsy recommendations of subclassifying epilepsy into clinical syndromes, 29 we undertook a further sensitivity analysis based solely on ICD-10 codes, based on work using Danish national registers. 30 Third, as an index of severity, we compared individuals whose fi rst hos pital treatment episode lasted for 9 days or more (90th percentile) with the others (inpatients and out patients). Fourth, we investigated diff erences by diagnostic threshold by comparing individuals with one or more diagnoses of epilepsy with those with two or more diagnoses. Fifth, we compared individuals with epilepsy by birth order. Finally, deaths by 10-year age-bands were investigated, and we also compared mortality risks in children who died under the age of 15 years with other ages. We followed STROBE guidelines (appendix).
Results
We identifi ed 69 995 individuals with epilepsy and compared them with 660 869 age-matched and sexmatched controls (table 1). Patients were followed up for an average of 9 years (interquartile range [IQR] 5-18 years). Rates of psychiatric comorbidity were 18·0% before diagnosis of epilepsy and 22·7% after diagnosis, with high rates of depression and substance misuse (drug and alcohol use disorders; table 2).
6155 (8·8%) patients with epilepsy died before the end of the follow-up period compared with 4892 (0·7%) controls. We found a substantially elevated increased odds for all-cause mortality in individuals with epilepsy after matching for age and sex (odds ratio 14·1, 95% CI 13·5-14·7), and after adjustment for sociodemographic confounders (adjusted odds ratio [aOR] 11·1, 95% CI 10·6-11·6). In men, 3786 (10·2%) patients died during follow-up, compared with 3322 (1·0%) controls (aOR 10·1, 95% CI 9·5-10·7); in women, 2369 (7·2%) patients died, compared with 1570 (0·5%) controls (13·0, 12·0-14·0). Adjusted odds ratios for ICD subcategories of mortality were mostly elevated (table 3) , with most deaths in patients with diseases caused by the same underlying disease process as that leading to epilepsy. Of these, neoplasms (23·0% of deaths; aOR 11·2, 95% CI 10·3-12·2), and diseases of the nervous system (21·3% of deaths; 71, 57-88) were the two major causes. The next largest category was external causes (15·8% of deaths). The highest mortality odds ratio was for conditions originating in the perinatal period (1·6% of deaths; aOR 126, 95% CI 46-348).
Patients, n (%) Controls, n (%)
Pre-existing diagnoses
The odds for external causes of death in individuals with epilepsy were also elevated (aOR 3·6, 95% CI 3·3-4·0; table 4). For suicide (n=510), the adjusted odds ratio was 3·7 (95% CI 3·3-4·2). Deaths caused by nonvehicle accidents (n=362) had the highest odds of death (aOR 5·5, 95% CI 4·7-6·5) among external causes (table 4) . For death by assault (n=30), the adjusted odds ratio was 2·8 (95% CI 1·6-4·8). In further analyses of non-vehicle accidents, we found 135 deaths (37·3% of non-vehicle accidents) due to accidental drug poisoning, 60 (16·6%) due to accidental falls, 55 (15·2%) drowning, and 112 (30·9%) other and unspecifi ed accidental deaths.
We compared patients with epilepsy (n=48 437) with their unaff ected siblings (n=81 396) for all-cause mortality, natural causes, and specifi c external causes. All risk estimates remained raised, including those for suicide (aOR 2·9, 95% CI 2·4-3·6) and non-vehicle accidents (6·3, 4·6-8·8; table 4). We found no evidence of familial confounding for non-vehicle accidents (since risk estimates were signifi cant and of the same magnitude as with the population controls).
Diff erences in mortality due to any external cause did not vary by severity and diagnostic thresholds in sensitivity analyses (table 5) . Although odds of death by external causes were lower in those with two or more diagnoses of epilepsy, this diff erence was not signifi cant, and con fi dence intervals overlapped. We found some evidence for diff erences by epilepsy types in odds of external cause mortality. Special epilepsy syndromes (ICD-10 G40.5, including G40.5L epileptic encephalopathy with con tinuous spike-and-wave during sleep) had higher odds of non-vehicle accidents (aOR 24·2, 95% CI 9·2-63·9) than other types of epilepsy (table 5) . For suicide, women had higher odds of death (aOR 5·0, 95% CI 4·0-6·3) than men (3·3, 2·8-3·8; interaction test p=0·002). After stratifi cation by age groups, we found some evidence of higher odds ratios of external causes of mortality with increasing age. We found no diff erences in odds or prevalence of mortality by birth order. Odds ratios of external causes were higher in the fi rst 6 months after diagnosis of epilepsy (table 5) . Sensitivity analyses for all natural causes of death, and specifi cally for neoplasms and neurological causes, are shown in the appendix.
Odds ratio for death compared with population controls (aOR [95% CI])
Odds ratio for death compared with unaff ected sibling controls (aOR [95% CI])
Other and unspecifi ed 4·9 (3·6-6·5) 5·2 (3·2-8·5)
Data are adjusted odds ratios (aOR) of external deaths compared with population controls (matched for age and sex, and adjusted for income, and marital and immigration status) or unaff ected sibling controls (adjusted for age and sex). Adjusted odds ratios refer to the odds of premature death by ICD chapter in patients with epilepsy compared with controls matched by sex and birth year, and adjusted by income, and immigrant and single status. There was an increased prevalence of psychiatric disorders in epilepsy patients, and specifi cally for alcohol and drug use disorders, and depression (table 2) . By epilepsy syndrome, special syndromes had higher comorbidity (81·3%) than unspecifi ed (45·2%), focal (36·0%), generalised (29·6%) and other groups. Of those who died from external causes during follow-up, 75% (731 of 972; aOR 10·6, 95% CI 9·2-12·2) had a lifetime psychiatric diagnosis (including substance misuse) and, specifi cally, 549 (56%; 22·4, 18·3-27·3) had a history of substance % deaths refers to proportion of all deaths for row category which were due to the column cause (eg, of the male deaths in epilepsy, 18·8% were from external causes). Adjusted odds ratios (aOR) report odds of mortality in individuals with epilepsy compared with general population controls (matched for age and sex, and adjusted for income, and marital and immigration statuses). Suicide category includes undetermined deaths. (table 6) . We found no diff erences in odds of mortality between psychiatric disorders diagnosed before epilepsy and those diagnosed after (data not shown). In those with psychiatric comorbidity, we found evidence for an association between epilepsy and external cause mortality (aOR 2·3, 95% CI 1·9-2·8), suicide (2·1, 1·5-2·9), vehicle accidents (1·9, 1·3-2·6), and non-vehicle accidents (aOR 3·5, 2·5-4·9). In addition, we looked at all natural causes of death, and the two most common causes (neoplasms, neurological) and did not fi nd strong associations with psychiatric comorbidity (appendix).
Discussion
Our results indicate high rates of premature mortality in epilepsy, and highlight the substantial contribution of psychiatric comorbidity to this mortality. The fi ndings potentially contribute to the clinical management of epilepsy for neurology, psychiatry, and primary care services by presenting information on associations with treatable psychiatric disorders. To our knowledge, this is the fi rst time that unaff ected sibling controls have been used to assess mortality in epilepsy (panel). We report three main fi ndings. First, the adjusted odds of all-cause mortality, which followed individuals with epilepsy until they were 56 years old, was 11 compared with both general population and unaff ected sibling controls. 16% of all epilepsy deaths were from external causes, which was the largest category of deaths that was not clearly related to underlying disease processes (such as brain tumours and infections). A notable fi nding was the high risk of death from non-vehicle accidents, with adjusted odds of death at 5·5 (95% CI 4·7-6·5). Second, we found evidence that epilepsy is an independent risk factor for all-cause and external causes of death. This was most clearly shown when we compared patients with their unaff ected siblings. For external causes, the odds of mortality in people with epilepsy were increased at 2·9 for suicide and 3·6 for accidents compared with unaff ected siblings.
The independent eff ect of epilepsy on suicide contrasts with some previous research, 7, 8 but supports another population study, 6 which found an independent eff ect of epilepsy on external causes of death. We believe our fi ndings are robust, since our study benefi ted from a large sample size, various sensitivity analyses, and examined familial confounding. Third, patients with epi lepsy and psychiatric comorbidity have very high mor tality. Specifi cally, individuals with epilepsy and comorbid depression had an odds ratio for suicide of 23 compared 
Depression
No epilepsy, no depression
Substance misuse
No epilepsy, no substance misuse
No epilepsy, substance misuse
Epilepsy, no substance misuse
Epilepsy, substance misuse
Number of deaths in epilepsy and associated controls, stratifi ed by psychiatric diagnoses. % is percentage of deaths from a particular cause within the row sample (eg, of those with no epilepsy and no psychiatric disorder, 0·2% died from external causes). Adjusted odds ratios (aOR) report odds of morality compared with the reference group. Suicide category includes undetermined deaths. Table 6 : Associations of external causes of death in epilepsy with psychiatric comorbidity with non-depressed general population controls, and those with epilepsy and comorbid substance misuse of 21. The corresponding odds of suicide in general popu lation controls with depression but without epilepsy was 10. For deaths from non-vehicle accidents, there was a strong association with substance misuse (as suggested by an increase in odds of mortality of 43 in epilepsy and comorbid substance misuse, compared with 20 in general population controls without epilepsy but with sub stance misuse).
The high odds associated with congenital conditions and those arising in the perinatal period, such as cerebral palsy, is not surprising, since these underlying conditions are associated with the most severe forms of epilepsy. This mortality risk underlines the importance of preventing these causes of death during the perinatal period and perhaps the need to examine interventions to prevent epileptogenesis in those exposed to perinatal events.
Our fi nding of an 11-fold increase in odds of all-cause mortality compared with general population controls is higher than that reported in some other mortality studies, but consistent with the few studies that have examined premature mortality. For example, one population study in Sweden found standardised mortality ratios between 10 and 14 in hospitalised patients aged 15-54 years. 4 Furthermore, we reported an increased odds of suicide of 3·7 that is within the range reported in a recent systematic review. 5 Although a few population based studies have presented data for psychiatric comorbidity, estimates in our study are within the range of 19-48% reported in a review article, 31 and consistent with the 36% found in a community survey of patients with epilepsy. 32 Additionally, our prevalence of depression of 8·9% is similar to the 9·6% found in a recent study of 7403 individuals with epilepsy in England. 33 Our fi ndings suggest that risks for external causes of death, and potential treatments to mitigate these risks, need to be considered in patients with epilepsy. The importance of identifying, monitoring, and treating psychiatric comorbidity, discussed recently in an expert review, 34 is underscored by these results. This was most clearly shown in our fi nding that around three-quarters of deaths from external causes in the epilepsy cohort were in patients who had a lifetime psychiatric diagnosis. In particular, patients with psychiatric comorbidity in the period immediately after the fi rst diagnosis of epilepsy represent a high-risk population that might benefi t from closer monitoring, consultation with liaison psychiatry, and more intensive treatments. But our results also highlight the role of other risk factors beyond psychiatric comorbidity as suicide and accident deaths were increased in those without lifetime co-occurring psychiatric disorders. Such risk factors may include more sensitive measures of disease course and severity than we were able to investigate, treatment-related factors, 5 and direct eff ects of the condition on decision making in some people. 35 Additionally, the importance of other causes of death is also underlined by our fi ndings; neurological causes had the highest rates and risks, and the contribution of sudden unexplained deaths needs further examination. 36 Moreover, our fi ndings highlight the importance of non-vehicle accidents as a major preventable cause of death in people with epilepsy. One possible implication is whether specifi c warnings and patient education, besides those already given, should be provided to patients about risks of non-vehicle accidents, including their link to substance misuse.
Although the relative risks were high, absolute rates of premature mortality from external causes were 1·4%, and any changes to clinical practice need to consider how to identify high-risk populations with low false positive rates. Nevertheless, as we found around a third of epilepsy patients had a comorbid psychiatric diagnosis, and around a tenth had comorbid substance misuse, clinical epilepsy services could review their liaison with psychiatric 37 and addiction services. The importance of substance misuse in suicide mortality was at least as important as depression, but it has not been highlighted in recent reviews. 34 Previous work has examined the role of alcohol comorbidity in suicide risk, 6 but little is known about comorbid drug use.
There are two main limitations in this study. The fi rst is that we restricted our cohort to those born between 1954 and 2009. This was done to focus on premature mortality and so that our fi ndings would not be potentially diluted by the large mortality eff ects of older people. This restriction also avoided cohort eff ects with older people, for whom services and treatments were considerably diff erent before 1970. Nevertheless, results are confi ned to premature deaths. A second limitation is that we used patient registers to identify people with epilepsy, since it
Panel: Research in context
Systematic review
We searched Medline for articles comparing mortality in epilepsy to general population controls and examining the role of psychiatric comorbidity, published up to March 29, 2013, with no language or date restrictions, and with the search terms "epilepsy" and ("mortality" or "death") and "psych*". We also scanned references of key articles. We identifi ed two population-based case-control studies. A Danish study 6 (n=492 suicides) found epilepsy to be a risk factor for suicide independent of increased risk of psychiatric comorbidity. A Canadian study 7 (n=203 fatal and non-fatal accidents, suicide and suicide attempts, and self-infl icted injuries), however, found no increased risk of external causes of death in epilepsy after adjusting for comorbidity.
Interpretation
Our study substantially increases the evidence on the contribution of psychiatric morbidity to mortality in epilepsy. Additionally, for the fi rst time, we examine odds of premature death in individuals with epilepsy compared with their unaff ected siblings, and fi nd that they do not diff er signifi cantly from mortality odds in epilepsy compared with general population controls. This strongly suggests that epilepsy is an independent risk factor for all-cause and external cause mortality. External causes of death were strongly associated with psychiatric conditions, and we conclude that premature mortality in epilepsy might be reduced with improved identifi cation and treatment of these comorbidities.
was necessary to use routinely collected data to provide precision for the fairly rare outcomes investigated.
Syndromal approaches are now recommended to subclassify epilepsy 29 and translating ICD codes into these syndromes might be subject to some misclassifi cation. 30 Nevertheless, using either ICD codes or syndromes, epilepsies that were not focal or generalised (and described variously as other or special epileptic syndromes) could incur higher risk of premature mortality. We used both outpatient and inpatient data to identify cases, and found no obvious diff erences in mortality. However, we might be missing a proportion of patients who never present to secondary services, although we estimate that this number would be small for a chronic illness such as epilepsy in a country with a comprehensive tax-funded health system such as Sweden, and over an average follow-up of 9 years. This small missing proportion is likely due to the longstanding practice for fi rst diagnoses of epilepsy to be confi rmed by specialist services. 38 Nevertheless, undersampling of patients with less severe symptoms could lead to an over estimation of the association with premature death if individuals with less severe disease are both less likely to be diagnosed and have fewer comorbidities and mortality risks.
We also only studied one country, and the generalisability to other countries is uncertain. An estimate of the prevalence of epilepsy based on our sample is diffi cult, since the 41 year cohort does not lend itself to such a calculation. However, when extrapolating the prevalence reported in this cohort to a lifetime prevalence, we fi nd a similar prevalence estimate to that reported in other high-income countries. 2 Sweden is not dissimilar to other western European countries in suicide rates 39 but comparative information on death by accidents is limited. Finally, some of the causes of death may be prone to misclassifi cation. Suicide and deaths from undetermined causes were combined to account for this, but it is possible that some accidental deaths are in fact suicides. 40 Some accidental deaths will also be a direct consequence of seizures, and therefore the associations with substance misuse might not be causal. Treatment trials in this population are necessary to determine the precise role of substance misuse and other psychiatric disorders on premature death. We were also unable to examine the eff ect of psychiatric comorbidity on sudden unexpected deaths in epilepsy which contribute to around 4% of deaths in community samples, 41 and are defi ned as death due to sudden and unexplained respiratory failure or cardiac arrest. 36 Future research should examine the relation between epilepsy, psychiatric comorbidity, and prescribed medication (particularly selective serotonin reuptake inhibitors) 42 on sudden unexpected deaths. However, we did examine the association of psychiatric morbidity with two main causes of natural deaths, namely cancer and neurological diseases (appendix). We did not fi nd strong associations with psychiatric comorbidity, which was not surprising since these underlying causes of epilepsy are likely to cause death directly.
We found no evidence of familial confounding in allcause and external mortality, a somewhat unexpected fi nding, as previous studies have suggested that familial (genetic or early environmental) eff ects explain a substantial part of the association between epilepsy and violent crime. 23 However, it strengthens the hypothesis that epilepsy is on the causal pathway to premature death.
In summary, psychiatric comorbidity has an important role in the premature mortality seen in epilepsy. Reducing premature mortality from external causes of death should be a priority in epilepsy management. The ability of health services to prevent such deaths requires review.
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